QYUNS THERAPEUTICS CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.1 HKD | -1.99% |
|
-4.24% | 0.00% |
| 06-17 | Qyuns Therapeutics Releases Data from Phase 2 Trial for Prurigo Nodularis Drug | MT |
| 05-30 | Qyuns Therapeutics Enrolls First Subject in Phase 3 Trial of Skin Disease Drug | MT |
